Aclaris Therapeutics, Inc. logo

Aclaris Therapeutics, Inc. (ACRS)

Market Open
12 Jun, 17:57
NASDAQ (NGS) NASDAQ (NGS)
$
4. 38
+0.01
+0.3432%
$
494.44M Market Cap
- P/E Ratio
- Div Yield
274,976 Volume
-1.64 Eps
$ 4.37
Previous Close
Add Transaction
Day Range
4.37 4.53
Year Range
1.34 5.15
Want to track ACRS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Aclaris Therapeutics, Inc. Investors

Name Quantity Cost Value Profit ($) Gain (%)
JC
Joseph Castro Nuveen LLC
118,020 $167,588.1 $519,288 $351,699.9 209.86%
LP
Li Peng China Universal Asset Management Co. Ltd.
17,655 $53,141.55 $77,505.45 $24,363.9 45.85%
TK
Taro Kuriyama Axq Capita LLP
24,186 $57,294.23 $106,176.54 $48,882.31 85.32%
Alexandra Stickelman
Alexandra Stickelman Root Financial Partners, LLC
27 $101 $118.8 $17.8 17.62%
AA
Andrew Alkon EntryPoint Capital, LLC
33,007 $123,776 $145,230.8 $21,454.8 17.33%
Christopher C. Powers
Christopher C. Powers Farther Finance Advisors, LLC
398 $1,010.93 $1,751.2 $740.27 73.23%
SAM
Smartleaf Asset Management LLC Smartleaf Asset Management LLC
376 $1,090 $1,654.4 $564.4 51.78%
MS
Mark Schafer Police & Firemen's Retirement System of New Jersey
19,700 $27,974 $86,680 $58,706 209.86%
YML
Yuen Man Lee Persistent Asset Partners Ltd.
22,259 $67,000 $97,939.6 $30,939.6 46.18%
GFM
GF Fund Management Co. Ltd. GF Fund Management Co. Ltd.
2,419 $7,496.22 $10,643.6 $3,147.38 41.99%